Description
BioReLift – Post Cream 200 ml is a professional post-procedure dermocosmetic cream developed to support skin recovery, hydration, and barrier comfort following aesthetic and dermatological treatments. The product is classified as a topical post-treatment skincare formulation and is not an injectable, implantable, or intradermal medical device [1].
BioReLift – Post Cream is designed for application after procedures that may temporarily disrupt the epidermal barrier, including injectable treatments, chemical peels, laser therapies, and microneedling. Its role is supportive, acting at the epidermal level to help maintain moisture balance and reduce post-procedure dryness or discomfort.
The formulation does not provide volumising, biostimulatory, or tissue-altering effects. Instead, it functions as an adjunctive component of structured post-procedure care protocols. BioReLift – Post Cream is supplied in a 200 ml format intended for professional environments and patient aftercare guidance, in accordance with manufacturer positioning and cosmetic regulatory standards .
What BioReLift – Post Cream Is Similar To
BioReLift – Post Cream belongs to the category of professional post-procedure skincare products, rather than injectable skin boosters or dermal fillers. It can be compared, for clinical orientation, to other topical recovery creams used after aesthetic treatments, such as post-laser or post-peel barrier-support formulations.
Products such as Neoviderm® Post Treatment Cream or Alastin® Regenerating Skin Nectar are often referenced in professional settings for similar aftercare purposes. These products share a topical mechanism of action focused on hydration and epidermal support, although they differ in formulation composition, texture, and regulatory positioning.
Unlike injectable skin boosters such as Profhilo®, BioReLift – Post Cream does not act within the dermis and does not provide biological stimulation or volumisation. Its effects are dependent on topical application and regular use rather than tissue persistence.
This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
BioReLift – Post Cream is intended for topical application on skin requiring hydration and comfort support following aesthetic or dermatological procedures.
Specific anatomical treatment areas are not provided by the manufacturer in publicly available documentation .
Usage / Administration (IFU-only section)
The following parameters are based strictly on available manufacturer and distributor information:
-
Route of administration: topical application
-
Injection depth: not applicable
-
Volume per point / injection site: not provided by manufacturer
-
Needle gauge: not applicable
-
Frequency / number of sessions: not provided by manufacturer
Professional-use disclaimer: BioReLift – Post Cream is intended for professional recommendation and use as part of post-procedure skincare protocols .
Some practitioners apply this product according to individual aftercare routines; this is not included in the manufacturer’s official IFU.
Ingredient List
Based on publicly available information:
-
Skin-conditioning and hydrating components (specific actives not disclosed by manufacturer)
-
Cosmetic excipients and stabilising agents (not provided by manufacturer)
HA concentration: not provided by manufacturer
Contains lidocaine: not applicable
Presentation & Longevity
-
Presentation: 1 × 200 ml container
-
Shelf life: not provided by manufacturer
-
Treatment longevity: not provided by manufacturer
Effects are associated with ongoing topical use rather than a defined duration of action.
Safety Notes / Contraindications
Detailed contraindications are not fully disclosed in public manufacturer documentation. Standard cosmetic aftercare precautions apply:
-
Contraindicated in individuals with known hypersensitivity to any component
-
Do not apply to actively infected or severely compromised skin unless advised by a qualified professional
-
For external use only
Regulatory Status
BioReLift – Post Cream is marketed in the EU and UK as a professional cosmetic post-procedure care product.
Regulatory classification is not specified in public documentation; verification should be completed via the product packaging or manufacturer information .
FAQ
Q1: Is BioReLift – Post Cream an injectable product?
No. BioReLift – Post Cream is a topical dermocosmetic product intended for external use only. It is not injected and does not act within the dermal or subdermal layers .
Q2: Can BioReLift – Post Cream replace injectable skin boosters?
No. BioReLift – Post Cream is designed to support post-procedure skin comfort and hydration. It does not provide volumising, biostimulatory, or structural effects associated with injectable products .
Q3: When is BioReLift – Post Cream typically used?
The product is positioned for use after aesthetic or dermatological procedures as part of post-treatment care. Specific timing and frequency are not detailed by the manufacturer .
Q4: How long do the effects of BioReLift – Post Cream last?
The manufacturer does not define a fixed duration of effect. Benefits depend on continued topical application rather than long-term tissue persistence .
Q5: Is BioReLift – Post Cream suitable for all skin types?
Public documentation does not specify skin-type limitations. Individual suitability should be assessed by a qualified professional, particularly in patients with sensitive or reactive skin .
